Patient
P2B-004
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · University of Iowa (Iowa City, IA) (Dr. Okafor)
consented 2012-03-23
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
Grade 2 weight decreased with onset in cycle 6 (2012-07-31); assessed as not related to study drug (not related); resolved 2012-09-13.
Grade 2 anaemia with onset in cycle 4 (2012-06-25); assessed as related to study drug (probable); resolved 2012-07-20.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.